These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 4869256)

  • 1. [New possibilities of treatment of septic shock].
    Dorobisz T
    Pol Tyg Lek; 1967 Dec; 22(51):1979-81. PubMed ID: 4869256
    [No Abstract]   [Full Text] [Related]  

  • 2. Kinin levels in experimental endotoxic shock.
    Fal W
    Arch Immunol Ther Exp (Warsz); 1969; 17(3):406-20. PubMed ID: 4895935
    [No Abstract]   [Full Text] [Related]  

  • 3. [The anti-shock effects of several drugs, with special reference to the effect of lidocaine].
    Tanaka K
    Masui; 1985 Feb; 34(2):165-72. PubMed ID: 2409305
    [No Abstract]   [Full Text] [Related]  

  • 4. Aprotinin therapy in septic shock.
    Putterman C
    Acta Chir Scand; 1989; 155(6-7):367. PubMed ID: 2479207
    [No Abstract]   [Full Text] [Related]  

  • 5. [The protease inhibitor aprotinin in the therapy of septic shock].
    Putterman C; Bshouty Z; Bursztein S
    Harefuah; 1986 Dec; 111(12):411-4. PubMed ID: 2435623
    [No Abstract]   [Full Text] [Related]  

  • 6. [Reticuloendothelial phagocytosis during endotoxic shock and the effect fo aprotinin on C3].
    Ogata H; Kim S
    Masui; 1983 Mar; 32(3):289-92. PubMed ID: 6191055
    [No Abstract]   [Full Text] [Related]  

  • 7. Experimental studies on the effect of prophylactic proteinase inhibitor therapy on endotoxin shock.
    Sumida S
    Adv Exp Med Biol; 1979; 120B():395-401. PubMed ID: 390988
    [No Abstract]   [Full Text] [Related]  

  • 8. The duration of hypotension before the initiation of antibiotic treatment is a critical determinant of survival in a murine model of Escherichia coli septic shock: association with serum lactate and inflammatory cytokine levels.
    Kumar A; Haery C; Paladugu B; Kumar A; Symeoneides S; Taiberg L; Osman J; Trenholme G; Opal SM; Goldfarb R; Parrillo JE
    J Infect Dis; 2006 Jan; 193(2):251-8. PubMed ID: 16362889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Various clinical considerations on shock].
    Cattaneo AD
    Minerva Anestesiol; 1970 Dec; 36(12):762-7. PubMed ID: 5314144
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of ATP and a proteolytic enzyme inhibitor in irreversible shock.
    Massion WH; Erdos EG
    J Okla State Med Assoc; 1966 Aug; 59(8):467-71. PubMed ID: 5296339
    [No Abstract]   [Full Text] [Related]  

  • 11. Current management of the septic shock patient: experimental basis for treatment.
    Hinshaw LB; Beller-Todd BK; Archer LT
    Circ Shock; 1982; 9(5):543-53. PubMed ID: 6756669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [TEG studies on the effect of trasylol on blood clotting and on the survival of animals in experimental shock].
    Pelasa J
    Pol Tyg Lek; 1969 Jan; 24(2):49-51. PubMed ID: 5305939
    [No Abstract]   [Full Text] [Related]  

  • 13. The effects of aprotinin on the phagocytic activity of the reticuloendothelial system and plasma prekallikrein levels during endotoxin shock.
    Ogata H; Kim S; Fukazawa T; Midorikawa Y; Yamashiro C
    Prog Clin Biol Res; 1983; 111():309-22. PubMed ID: 6191338
    [No Abstract]   [Full Text] [Related]  

  • 14. Phenyoxybenzamine in endotoxin shock.
    Masucci FD; Hinshaw LB; Reins D
    J Okla State Med Assoc; 1966 Aug; 59(8):432-6. PubMed ID: 5329375
    [No Abstract]   [Full Text] [Related]  

  • 15. A review of septic shock.
    Hardaway RM
    Am Surg; 2000 Jan; 66(1):22-9. PubMed ID: 10651342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of surfactants in rat in septic shock.
    Brotzu G; Dazzi E; Savona G; Pinna M; Spada MC
    Bibl Anat; 1979; (18):367-8. PubMed ID: 315226
    [No Abstract]   [Full Text] [Related]  

  • 17. [Successful treatment with protease inhibitor of endotoxic shock caused by plasma transfusion].
    Dorobisz T; Borodej-Dzierzkowa W; Hirnlowa L; Rybusińska-Lebuda J; Kompoltowicz Z
    Pol Tyg Lek; 1971 Apr; 26(14):518-9. PubMed ID: 5314002
    [No Abstract]   [Full Text] [Related]  

  • 18. Fructose-1,6-diphosphate: an agent for treatment of experimental endotoxin shock.
    Markov AK; Turner MD; Oglethorpe N; Neely WA; Hellems HK
    Surgery; 1981 Sep; 90(3):482-8. PubMed ID: 6455765
    [No Abstract]   [Full Text] [Related]  

  • 19. Endotoxin shock in septic abortions.
    Hirvonen E
    Ann Chir Gynaecol Fenn; 1971; 60(4):196-201. PubMed ID: 4945493
    [No Abstract]   [Full Text] [Related]  

  • 20. Microcirculation in endotoxin shock.
    Bains JW; Bond TP; Lewis SR
    Surg Forum; 1965; 16():484-5. PubMed ID: 5319690
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.